Duchmann, Matthieu
Yalniz, Fevzi F.
Sanna, Alessandro
Sallman, David
Coombs, Catherine C.
Renneville, Aline
Kosmider, Olivier
Braun, Thorsten
Platzbecker, Uwe
Willems, Lise
Adès, Lionel
Fontenay, Michaela
Rampal, Raajit
Padron, Eric
Droin, Nathalie
Preudhomme, Claude
Santini, Valeria
Patnaik, Mrinal M.
Fenaux, Pierre
Solary, Eric
Itzykson, Raphael
Funding for this research was provided by:
Novartis
Ligue Contre le Cancer
Janssen Biotech
Ministère des Affaires Sociales et de la Santé (PHRC MAD-06)
Celgene
Childhood Cancer Canada
AbbVie
Janssen Pharmaceuticals
Association Laurette Fugain (ALF-2014-10)
This article is maintained by: Elsevier
Article Title: Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
Journal Title: EBioMedicine
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ebiom.2018.04.018
Content Type: article
Copyright: © 2018 The Authors. Published by Elsevier B.V.